sulfacetamide   Click here for help

GtoPdb Ligand ID: 12633

Synonyms: Bleph-10® | Klaron® | sulphacetamide
Approved drug
sulfacetamide is an approved drug (FDA (1945))
Compound class: Synthetic organic
Comment: Sulfacetamide is a sulfonamide antibacterial compound that has been in clinical use since the 1940s [3]. It inhibits the bacterial dihydropteroate synthase pathway which generates the folic acid that is essential for bacterial growth.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 97.64
Molecular weight 214.24
XLogP -0.99
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N
Isomeric SMILES CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N
InChI InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)
InChI Key SKIVFJLNDNKQPD-UHFFFAOYSA-N
References
1. Achari A, Somers DO, Champness JN, Bryant PK, Rosemond J, Stammers DK. (1997)
Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
Nat Struct Biol, 4 (6): 490-7. [PMID:9187658]
2. Bermingham A, Derrick JP. (2002)
The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery.
Bioessays, 24 (7): 637-48. [PMID:12111724]
3. DUEMLING WW. (1954)
Sodium sulfacetamide in topical therapy.
AMA Arch Derm Syphilol, 69 (1): 75-82. [PMID:13113725]
4. Ovung A, Bhattacharyya J. (2021)
Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions.
Biophys Rev, 13 (2): 259-272. [PMID:33936318]